Category: fda

KHN’s ‘What the Health?’: Sharing Vaccines With the World

The Biden administration is bucking the drug industry and backing a waiver of covid-19 vaccine patent protections to help the rest of the world vaccinate its populations. Here at home, the Food and Drug Administration wants to ban menthol flavorings for cigarettes, setting off a fight with the tobacco industry. Alice Miranda Ollstein of Politico, Tami Luhby of CNN and Kimberly Leonard of Business Insider join KHN’s Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.

Detecting Rare Blood Clots Was a Win, But US Vaccine Safety System Still Has Gaps

With some 100 million Americans fully vaccinated, the U.S. is relying on a patchwork network of vaccine monitoring systems that lack the breadth and depth of large, population-based programs, experts said.

KHN’s ‘What the Health?’: Pause and Effect on Covid Vaccines

Podcast panelists discuss a range of health policy developments, from the latest in the covid vaccination effort to the HHS budget, among other things.

The FDA Seeks a New Way to Review Old Drugs Without Causing Prices to Soar

A misguided federal program called the Unapproved Drugs Initiative, which put the FDA’s stamp of approval on old drugs, led to higher prices. It’s scrapped. So now what?

A Year Into Pandemic, Federal Officials Design New Mask Guidelines to Better Protect More Workers

Changes would allow N95 sales for industries other than healthcare and signal an end to the hospital practice of reusing the masks considered essential for worker safety.

Analysis: How the US Invested in the War on Terrorism at the Cost of Public Health

After 9/11, as our defenses against international and bioterrorism hardened, our defenses against infectious diseases shrank. By the time a deadly virus arrived on our shores last year, nearly two-thirds of Americans were living in counties that spend more than twice as much on policing as they spend on public health.

Scientists Seek Covid Treatment Answers in Cheap, Older Drugs

Philanthropies are funding studies of cheap, existing medications like the antidepressant fluvoxamine as covid treatments. But early hype about hydroxychloroquine and other repurposed drugs leaves researchers leery of hasty conclusions.

KHN’s ‘What the Health?’: Getting Down to Work at HHS

After a bruising confirmation process, Xavier Becerra was sworn in as secretary of Health and Human Services this week. The Senate also confirmed the nominations of former U.S. Surgeon General Vivek Murthy to return to the post he held in the Obama administration, and former Pennsylvania health secretary Rachel Levine as assistant secretary for health. Levine is the first openly transgender person to receive Senate confirmation. Meanwhile, questions continue to swirl around the AstraZeneca covid vaccine, which some public health experts worry will create more hesitancy toward other vaccines.

Birx Joins Air-Cleaning Industry Amid Land Grab for Billions in Federal Covid Relief

Air-cleaning companies with limited oversight are targeting a growing market of schools desperate for covid-19 protection. Donald Trump’s former covid adviser lands with one that built its business, in part, on ozone-emitting technology.

The Hype Has Faded, but Don’t Count Out Convalescent Plasma in Covid Battle

The once-promising therapy that infuses blood plasma from recovered covid-19 patients into newly infected people, theoretically to boost immunity, has suffered setbacks. But some proponents say it’s too early to abandon the treatment.